Revenue grew 12.5% year-over-year to ¥1.01 billion, but net profit fell 28.7% to ¥225 million due to lower gross margins and acquisition-related amortization. The company expanded plasma collection, divested non-core assets, and advanced its intelligent factory, while facing ongoing price and policy pressures.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.